Portfolio

  • portfolio

    US and EU regulatory authorities have endorsed the development plan of Modufolin®

    The Active Pharmaceutical ingredients (API) is produced by Merck, according to GMP, at commercial grade and scale. The Final Drug…

    by
  • portfolio

    Modufolin® has the potential to replace all folate in cancer treatments

    Modufolin® is the key active folate metabolite responsible for the therapeutic effect, it has the potential to offer a significant…

    by
  • portfolio

    The majority of people do not fully benefit from their folate treatment today

    A few genes determine a persons ability to metabolize folates. All folate drugs used today, including, leucovorin and levoleucovorin, need…

    by
  • portfolio

    Folates are the most commonly used cancer drug today

    As part of their cancer treatment, more than 500 000 patients are treated with folates annually, in the US Europe…

    by